BOSTON - PepGen Inc. (NASDAQ: PEPG), a biotechnology firm focused on oligonucleotide therapies for severe neuromuscular and neurological diseases, is progressing with its CONNECT clinical program for ...
My parents are both retired medical professionals who are in their early 70s. My father has diabetes that he manages with medication, and he also has a history ...